Manufacturers

Aqueduct Medical Inc.

13, Wadi El-Hag , 1711102 Nazareth
Israel

Telephone +972 4 6098614
Fax +972 4 6564129
info@aqdmedical.com

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Trade fair hall

  • Hall 16 / G41
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 16): stand G41

Fairground map

MEDICA 2016 fairground map: Hall 16

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.08  Surgery and Endoscopy
  • 01.08.02  Surgical instruments and products

Surgical instruments and products

  • 01  Electromedical equipment / Medical Technology
  • 01.08  Surgery and Endoscopy
  • 01.08.02  Surgical instruments and products
  • 01.08.02.10  Dilatators

Our products

Product category: Dilatators

Innovative Cervical Dilator Device

The Aqueduct device combines the advantages of rods dilation and Laminaria and enables radial dilation (as with laminaria) within minutes (as with Hegar’s rods).

Competitive advantages:

•  Easy to operate and fast dilation procedure: Provides gradual and uniform dilation to a predetermined diameter within minutes.

•  Increases the accuracy and safety of the procedure: Eliminates dilation failure

•  Single act of insertion through the cervix: Reduces the risk of infection, perforation, and cervical incompetence.

•  Reduction of need for local or general anesthesia.

Clinical study – Human trials in a leading Spanish research and medical center, Hospital General Santa María del Puerto Cádiz. In all cases, the cervices were successfully dilated to the desired diameter in the targeted length of time.
The doctors expressed their satisfaction from the performance of the device, simplicity and short duration of the process.
Intellectual property – PCT application filled covering catheter’s innovating dilation method

CE Notified body #0459

Certification #30642

More Less

About us

Company details

Aqueduct Medical Ltd. Alleviates the discomfort and the potential complications to which millions of women each year are exposed when undergoing cervical dilation prior to intrauterine procedures.

Market & Unmet Need:
Approximately 3 million cervical dilations are performed annually in the United States for the purpose of intra-uterine procedures including: abortions, hysteroscopies, and other dilation & curettages. Cervical dilation allows medical practitioners greater access to the inside of the uterus in order to insert surgical tools for the completion of intra-uterine procedures. Until now, there have been primarily two techniques for dilating the cervix. The first technique is the insertion of laminaria (dry, sterile seaweed) into the cervix. When laminaria comes into contact with body fluids, it expands and enlarges the opening of the cervix. Often, this process requires two patient visits and approximately 10-12 hours for sufficient dilation to occur. The second technique, referred to as Hegar dilation, involves the insertion and removal of metal rods that are graduated in increasing diameter. This process is painful, requiring the use of anesthesia, and is associated with a risk of uterine and cervix damage (cervical incompetence).
 
Approximately 3 million cervical dilations are performed annually in the United States for the purpose of intra-uterine procedures including: abortions, hysteroscopies, and other dilation & curettages. Cervical dilation allows medical practitioners greater access to the inside of the uterus in order to insert surgical tools for the completion of intra-uterine procedures. Until now, there have been primarily two techniques for dilating the cervix. The first technique is the insertion of laminaria (dry, sterile seaweed) into the cervix. When laminaria comes into contact with body fluids, it expands and enlarges the opening of the cervix. Often, this process requires two patient visits and approximately 10-12 hours for sufficient dilation to occur. The second technique, referred to as Hegar dilation, involves the insertion and removal of metal rods that are graduated in increasing diameter. This process is painful, requiring the use of anesthesia, and is associated with a risk of uterine and cervix damage (cervical incompetence.
 
Aqueduct Medical Ltd. is an Israeli start-up company founded in August, 2013 and operates within the NGT technology incubator. The company specializing in the research and development of advanced Obstetric/Gynecological tools. Aqueduct -100, the company’s first product is a cutting-edge, innovative cervical dilator that combines the benefits of laminaria and Hegar Rods (the current methods) through lower risk of uterine perforation, lower rate of cervical incompetence, elimination of need for general anesthesia, and reduced number of patient visits.

More Less